Episode 900: Ketamine Dosing

Episode 900: Ketamine Dosing

Up next

Podcast 1001: Acute Intermediate Risk Pulmonary Embolism

Contributor: Aaron Lessen, MD Educational Pearls: Patients with pulmonary embolism (PE) are divided into three risk categories Low risk (non-massive PE): patients are stable Treatment: prescribe anticoagulants and discharge home Intermediate risk (submassive PE): patients are sta ...  Show more

Celebrating 1000 Medical Minutes

Hosts: Don Stader, Nate Novotny, Travis Barlock, and Jeffrey Olson In this episode, we reminice about the first 1000 medical minutes presented by EMM and what the next 1000 might hold. Below are all of the episodes referenced in this episode. Please go back and give them all a li ...  Show more

Recommended Episodes

Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity
Huberman Lab

In this episode, I explain how ketamine causes rewiring of brain circuits and dissociative states to relieve symptoms of depression and post-traumatic stress disorder (PTSD). I explain how ketamine impacts both the brain’s glutamate and its endogenous opioid pathways, which toget ...  Show more

PsychEd Episode 34: Ketamine for Treatment-Resistant Depression with Dr. Sandhya Prashad
PsychEd: Educational Psychiatry Podcast

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers ketamine for treatment-resistant depression (TRD) with Dr. Sandhya Prashad, a psychiatrist and the founder and medical director of Houston Ketamine Therapeutics. She has exte ...  Show more

Ketamine Therapy with Dr. Mike Dow
Braincare

Dr. Mike Dow is healing severe mental disorders with ketamine. The certified psychedelic ketamine-assisted psychotherapist advocates for the drug that is more effective than standard antidepressants. Today, Dr. Dow shares the history of ketamine and how it has been developed to h ...  Show more

Ketamine-- Lessons from 3000 Sessions
Back from the Abyss: Psychiatry in Stories | Psychotherapy, Trauma, and Psychedelics

Some of the most basic questions about ketamine are still under investigation— Which patients are ideal responders? What is the therapeutic dose range? Is there a meaningful dose/response curve? Are fully dissociative treatments necessary for optimal efficacy? How important is ...

  Show more